-+ 0.00%
-+ 0.00%
-+ 0.00%

OS Therapies Appoints Frank Knuettel II As CFO

Benzinga·10/01/2026 12:34:01
Listen to the news

OS Therapies, Inc. (NYSE:OSTX) ("OS Therapies" or the "Company"), the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced the appointment of Kerry Clem as Chief Commercial Officer (CCO) and Frank Knuettel II as Chief Financial Officer (CFO).